ROCKWELL MEDICAL INC (RMTI)
US7743743004 - Common Stock
Overall RMTI gets a fundamental rating of 4 out of 10. We evaluated RMTI against 187 industry peers in the Health Care Equipment & Supplies industry. The financial health of RMTI is average, but there are quite some concerns on its profitability. RMTI is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year RMTI has reported negative net income.
In the past year RMTI had a positive cash flow from operations.
RMTI had negative earnings in each of the past 5 years.
In the past 5 years RMTI always reported negative operating cash flow.
1.2 Ratios
With a decent Return On Assets value of -2.17%, RMTI is doing good in the industry, outperforming 66.84% of the companies in the same industry.
RMTI has a Return On Equity of -4.24%. This is in the better half of the industry: RMTI outperforms 67.91% of its industry peers.
Looking at the Return On Invested Capital, with a value of 1.06%, RMTI is in the better half of the industry, outperforming 67.38% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.17% | ||
| ROE | -4.24% | ||
| ROIC | 1.06% |
ROA(3y)-41.16%
ROA(5y)-48.05%
ROE(3y)-486.08%
ROE(5y)-343.32%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
RMTI has a Operating Margin of 0.59%. This is in the better half of the industry: RMTI outperforms 66.84% of its industry peers.
The Gross Margin of RMTI (16.91%) is worse than 80.75% of its industry peers.
In the last couple of years the Gross Margin of RMTI has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.59% | ||
| PM (TTM) | N/A | ||
| GM | 16.91% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y33.36%
GM growth 5YN/A
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so RMTI is destroying value.
The number of shares outstanding for RMTI has been increased compared to 1 year ago.
Compared to 5 years ago, RMTI has more shares outstanding
The debt/assets ratio for RMTI has been reduced compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of -6.10, we must say that RMTI is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -6.10, RMTI is not doing good in the industry: 72.73% of the companies in the same industry are doing better.
The Debt to FCF ratio of RMTI is 3.99, which is a good value as it means it would take RMTI, 3.99 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.99, RMTI belongs to the top of the industry, outperforming 84.49% of the companies in the same industry.
RMTI has a Debt/Equity ratio of 0.34. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.34, RMTI is in line with its industry, outperforming 47.59% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.34 | ||
| Debt/FCF | 3.99 | ||
| Altman-Z | -6.1 |
ROIC/WACC0.11
WACC9.35%
2.3 Liquidity
RMTI has a Current Ratio of 2.41. This indicates that RMTI is financially healthy and has no problem in meeting its short term obligations.
With a Current ratio value of 2.41, RMTI perfoms like the industry average, outperforming 42.25% of the companies in the same industry.
RMTI has a Quick Ratio of 2.00. This is a normal value and indicates that RMTI is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.00, RMTI is in line with its industry, outperforming 49.20% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.41 | ||
| Quick Ratio | 2 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 90.73% over the past year.
The Revenue has grown by 22.38% in the past year. This is a very strong growth!
RMTI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.69% yearly.
EPS 1Y (TTM)90.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%171.43%
Revenue 1Y (TTM)22.38%
Revenue growth 3Y10.36%
Revenue growth 5Y5.69%
Sales Q2Q%19.12%
3.2 Future
RMTI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.99% yearly.
Based on estimates for the next years, RMTI will show a quite strong growth in Revenue. The Revenue will grow by 15.20% on average per year.
EPS Next Y106.37%
EPS Next 2Y36.37%
EPS Next 3Y25.99%
EPS Next 5YN/A
Revenue Next Year19.4%
Revenue Next 2Y-0.57%
Revenue Next 3Y2.48%
Revenue Next 5Y15.2%
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
RMTI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year RMTI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, RMTI is valued a bit cheaper than 79.68% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, RMTI is valued cheaply inside the industry as 85.56% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 25.51 | ||
| EV/EBITDA | 19.18 |
4.3 Compensation for Growth
RMTI's earnings are expected to grow with 25.99% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y36.37%
EPS Next 3Y25.99%
5. Dividend
5.1 Amount
No dividends for RMTI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
ROCKWELL MEDICAL INC
NASDAQ:RMTI (12/20/2024, 8:00:01 PM)
Premarket: 2.08 0 (0%)2.08
+0.03 (+1.46%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners21.01%
Inst Owner Change50.62%
Ins Owners2.24%
Ins Owner Change-0.13%
Market Cap67.23M
Analysts82.5
Price Target6.63 (218.75%)
Short Float %3.45%
Short Ratio1.22
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)257.7%
Min EPS beat(2)125.21%
Max EPS beat(2)390.2%
EPS beat(4)3
Avg EPS beat(4)124.58%
Min EPS beat(4)-47.06%
Max EPS beat(4)390.2%
EPS beat(8)6
Avg EPS beat(8)72.03%
EPS beat(12)10
Avg EPS beat(12)61.29%
EPS beat(16)11
Avg EPS beat(16)45.6%
Revenue beat(2)2
Avg Revenue beat(2)7.63%
Min Revenue beat(2)4.77%
Max Revenue beat(2)10.49%
Revenue beat(4)3
Avg Revenue beat(4)3.35%
Min Revenue beat(4)-4.31%
Max Revenue beat(4)10.49%
Revenue beat(8)6
Avg Revenue beat(8)3.8%
Revenue beat(12)7
Avg Revenue beat(12)0.27%
Revenue beat(16)7
Avg Revenue beat(16)-2.93%
PT rev (1m)-13.33%
PT rev (3m)-13.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)250%
EPS NY rev (1m)183.33%
EPS NY rev (3m)183.33%
Revenue NQ rev (1m)-3.48%
Revenue NQ rev (3m)1.55%
Revenue NY rev (1m)0.31%
Revenue NY rev (3m)0.31%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.68 | ||
| P/FCF | 25.51 | ||
| P/OCF | 20.41 | ||
| P/B | 2.31 | ||
| P/tB | 3.76 | ||
| EV/EBITDA | 19.18 |
EPS(TTM)-0.05
EYN/A
EPS(NY)-0.06
Fwd EYN/A
FCF(TTM)0.08
FCFY3.92%
OCF(TTM)0.1
OCFY4.9%
SpS3.06
BVpS0.9
TBVpS0.55
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.17% | ||
| ROE | -4.24% | ||
| ROCE | 1.35% | ||
| ROIC | 1.06% | ||
| ROICexc | 1.83% | ||
| ROICexgc | 3.31% | ||
| OM | 0.59% | ||
| PM (TTM) | N/A | ||
| GM | 16.91% | ||
| FCFM | 2.66% |
ROA(3y)-41.16%
ROA(5y)-48.05%
ROE(3y)-486.08%
ROE(5y)-343.32%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y33.36%
GM growth 5YN/A
F-Score6
Asset Turnover1.73
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.34 | ||
| Debt/FCF | 3.99 | ||
| Debt/EBITDA | 3.59 | ||
| Cap/Depr | 30.13% | ||
| Cap/Sales | 0.67% | ||
| Interest Coverage | 0.63 | ||
| Cash Conversion | 119.05% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.41 | ||
| Quick Ratio | 2 | ||
| Altman-Z | -6.1 |
F-Score6
WACC9.35%
ROIC/WACC0.11
Cap/Depr(3y)333.86%
Cap/Depr(5y)240.55%
Cap/Sales(3y)5.45%
Cap/Sales(5y)3.8%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)90.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%171.43%
EPS Next Y106.37%
EPS Next 2Y36.37%
EPS Next 3Y25.99%
EPS Next 5YN/A
Revenue 1Y (TTM)22.38%
Revenue growth 3Y10.36%
Revenue growth 5Y5.69%
Sales Q2Q%19.12%
Revenue Next Year19.4%
Revenue Next 2Y-0.57%
Revenue Next 3Y2.48%
Revenue Next 5Y15.2%
EBIT growth 1Y107.16%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y110.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y112.75%
OCF growth 3YN/A
OCF growth 5YN/A